We are thrilled to announce that mTatt has received a $10,000 grant to participate in the Lab2Market Validate program. This 16-week full-time program is designed to help researchers test and validate their ideas in the entrepreneurial landscape. Through mentorship, workshops, and funding, it provides the tools and guidance needed to explore a project’s commercial potential.

For mTatt, this program will be invaluable in validating the market for our microneedle tattoo technology. It allows us to engage directly with potential users and stakeholders, gather feedback on needs and preferences, identify real-world applications, and refine our business model. This process ensures that our innovation is not only scientifically groundbreaking but also meets real market needs.

Participating in Lab2Market Validate brings us closer to turning our vision of minimally invasive, real-time physiological monitoring into a solution that truly serves the health and wellness of patients.